title: Comparisons of ketoconazole, PR 969-566, PR 967-234, and PR 967-248 as antifungals in vitro and in the rat model of candidal vaginitis based on efficacy/safety profiles.
authors.affiliation: Pharmaceutical Division, Pennwalt Corporation, Rochester, New York 14623.
authors.forename: G C
authors.initials: GC
authors.lastname: Palmer
authors.forename: J M
authors.initials: JM
authors.lastname: Ordy
authors.forename: R D
authors.initials: RD
authors.lastname: Simmons
authors.forename: J C
authors.initials: JC
authors.lastname: Strand
authors.forename: G B
authors.initials: GB
authors.lastname: Mullen
authors.forename: C R
authors.initials: CR
authors.lastname: Kinsolving
authors.forename: V
authors.initials: V
authors.lastname: St Georgiev
authors.forename: S D
authors.initials: SD
authors.lastname: Allen
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D002175:Candida / Q000187:drug effects; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D004195:Disease Models, Animal; D005260:Female; D005658:Fungi / Q000187:drug effects; D007555:Isoxazoles / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D007654:Ketoconazole / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D008826:Microbial Sensitivity Tests; D010080:Oxazoles / Q000627:therapeutic use*; D051381:Rats
chemical_list: D000935:Antifungal Agents; D007555:Isoxazoles; D010080:Oxazoles; C058224:PR 967234; C058223:PR 969566; C058225:PR 967248; D007654:Ketoconazole